(Q34672957)

3 August 2017

title

Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk (English)

1 reference

3 August 2017

main subject

cardiovascular disease

1 reference

Harold Bays

1 reference

3 August 2017

Helena W Rodbard

series ordinal

1 reference

3 August 2017

Alan Bruce Schorr

series ordinal

1 reference

3 August 2017

J Michael González-Campoy

series ordinal

1 reference

3 August 2017

publication date

1 August 2007

1 reference

Current treatment options in cardiovascular medicine

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

259-271

1 reference

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

3 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-007-0021-6

Systematic review: an evaluation of major commercial weight loss programs in the United States

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-007-0021-6

The melanocortin system as a therapeutic treatment target for adiposity and adiposopathy

21 January 2018

1 reference

12 December 2020

Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets

1 reference

12 December 2020

Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

1 reference

12 December 2020

Aortic valvular regurgitation: prevalence and clinical characteristics in a predominantly obese adult population not taking anorexigens.

1 reference

12 December 2020

Glucocorticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cell precursors

1 reference

12 December 2020

Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial

1 reference

12 December 2020

The effects of exercise training on fat-mass loss in obese patients during energy intake restriction.

1 reference

12 December 2020

Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine

1 reference

12 December 2020

The science behind weight loss diets--a brief review.

1 reference

12 December 2020

Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects

1 reference

12 December 2020

Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything

1 reference

12 December 2020

Spontaneous and experimental human obesity: Effects of diet and adipose cell size on lipolysis and lipogenesis

1 reference

12 December 2020

Add-on combination and maintenance treatment: case series of five obese patients with different eating behavior

1 reference

12 December 2020

Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype

1 reference

12 December 2020

Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients

1 reference

12 December 2020

Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity. Effects of dietary composition and adipose cell size

1 reference

12 December 2020

Does central obesity reflect "Cushing's disease of the omentum"?

1 reference

12 December 2020

Melanin-concentrating hormone: from fish skin to skinny mammals

1 reference

12 December 2020

Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'?

1 reference

12 December 2020

Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus

1 reference

12 December 2020

Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?

1 reference

12 December 2020

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

1 reference

12 December 2020

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

1 reference

12 December 2020

Competing impact of excess weight versus cardiorespiratory fitness on cardiovascular risk

1 reference

12 December 2020

Adiposopathy is a more rational treatment target for metabolic disease than obesity alone

1 reference

12 December 2020

Rating the diets from Atkins(TM) to Dr. Sears Zone

1 reference

12 December 2020

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

1 reference

12 December 2020

The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys

1 reference

12 December 2020

Roles of amylin in diabetes and in regulation of nutrient load

1 reference

12 December 2020

Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity

1 reference

12 December 2020

The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients

1 reference

12 December 2020

What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials.

1 reference

12 December 2020

Adipose tissue as an endocrine organ

1 reference

12 December 2020

Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1.

1 reference

12 December 2020

Role of adipose tissue as an inflammatory organ in human diseases

1 reference

12 December 2020

Orlistat, sibutramine, or combination therapy: which performs better on waist circumference in relation with body mass index in obese patients?

1 reference

12 December 2020

Effect of weight loss with lifestyle intervention on risk of diabetes

1 reference

12 December 2020

Serotonergic drugs : effects on appetite expression and use for the treatment of obesity

1 reference

12 December 2020

Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.

1 reference

12 December 2020

Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients

1 reference

12 December 2020

Current and investigational antiobesity agents and obesity therapeutic treatment targets

1 reference

12 December 2020

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

1 reference

12 December 2020

Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia

1 reference

12 December 2020

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

1 reference

12 December 2020

The dietary approach to obesity: is it the diet or the disorder?

1 reference

12 December 2020

Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease

1 reference

12 December 2020

10.1007/S11936-007-0021-6

Identifiers

DOI

1 reference

3 August 2017

1 reference